MoonLake Immunotherapeutics

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phas…

Biotechnology

CH, Zug [HQ]

Competitors · Subsidiaries · Locations

Context Analysis

Competitors · Subsidiaries · Locations

The Contextualizer is eligible to "contextualize" the market relationships of MoonLake Immunotherapeutics,
e.g. through tracking it's acquisitions, subsidiaries, offices, fabrics and competitors around the globe.

Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.

U.S. · Business Intelligence

The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.

Worldwide · Business Intelligence

The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.

Worldwide · Competitors Table

Sourced from FMP or manual.

Competitor	Source	Accuracy	Country	City
Nuvalent, Inc.	FMP	High	United States	Cambridge
Structure Therapeutics Inc.	FMP	High	United States	South San Francisco
Arcellx, Inc.	FMP	High	United States	Gaithersburg
Akero Therapeutics, Inc.	FMP	High	United States	South San Francisco
Cerevel Therapeutics Holdings, Inc.	FMP	High	United States	Cambridge

Worldwide · Subsidiaries Table

Sourced from the SEC, through government awards and manual entries.

Subsidiary	Private?	Country	City
-	-	-	-